A Randomized Controlled Trial of Acupressure for Anxiety

Overview

About this study

The purpsoe of this stduy is to compare anxiety scores before and after a nurse-led acupressure intervention; we hypothesize that true acupressure will significantly decrease anxiety scores, as compared with sham acupressure. Then, we will teach patients to self-administer true vs sham acupressure to test the efficacy of self-administered acupressure for anxiety. We will also investigate whether true vs sham acupressure alleviates nausea. The ultimate goal of this research is to mitigate acute anxiety experienced by patients with cancer, using well-tolerated and widely generalizable interventions.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Registration: Inclusion Criteria for Nurse-Led Intervention

  • Age ≥18 years and be diagnosed with cancer.

  • Undergoing systemic, antineoplastic therapy.

  • Ability to provide oral consent.

  • Willingness to undergo a nurse-led acupressure intervention.

  • Willingness and ability to complete pre- and post-intervention questionnaires in English .

  • Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)

Inclusion Criteria for Self-Administered Intervention

All of the above AND

  • Reports 2+/day anxiety episodes at home.
  • Interested in learning self-administered acupressure.

Exclusion Criteria: 

  • Less than 18 years of age. 

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/27/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Cathcart-Rake, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available